Cleveland Biolabs Revenue and Competitors
Estimated Revenue & Valuation
- Cleveland Biolabs's estimated annual revenue is currently $3.5M per year.
- Cleveland Biolabs's estimated revenue per employee is $166,667
- Cleveland Biolabs's total funding is $111.1M.
Employee Data
- Cleveland Biolabs has 21 Employees.
- Cleveland Biolabs grew their employee count by -30% last year.
Cleveland Biolabs's People
| Name | Title | Email/Phone |
|---|
Cleveland Biolabs Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Cleveland Biolabs?
Cleveland Biolabs Inc. (CBL) is a biotech company that develops drugs for cancer threatment and protection from radiation. New therapeutic concepts of CBL’s scientific founder, Dr. Andrei Gudkov, combined with a new source of pharmaceutical substances and strong expertise in cancer biology form the proprietary technological foundations of CBL. CBL’s institutional founders, Cleveland Clinic Foundation (CCF) and ChemBridge Corp., provide critical intellectual property and unique technical capabilities to support ongoing drug development efforts. CBL's technological pipeline is suited for the development of new pharmaceuticals and their rapid preclinical evaluation. These pharmaceuticals include:
keywords:N/A
$111.1M
Total Funding
21
Number of Employees
$3.5M
Revenue (est)
-30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cleveland Biolabs News
... company related to the merger between Cleveland BioLabs and Cytocom; unexpected costs, charges or expenses resulting from the merger;...
Roswell Park has no current contracts with Cleveland BioLabs and has not since July 2018, Annie Deck-Miller, the spokesperson, said in an...
Abramovich's investment in Cleveland BioLabs isn't his only foray into the U.S. pharmaceutical industry. Over the past five years he has also...
Other Companies in Buffalo
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.3M | 21 | -16% | $3.3M |
#2 | $2.1M | 21 | N/A | N/A |
#3 | $3.2M | 21 | -19% | N/A |
#4 | $2.1M | 21 | 5% | N/A |
#5 | $2.1M | 21 | -16% | N/A |